FDA
label_change
· 2021-09-20
FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA action on Sun Pharmaceutical's supplemental application for desvenlafaxine, likely updating labeling or expanding indications. The submission concerns the d…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE)